Pathology player Healius has posted a stellar start to the year with a 44 per cent jump in group revenue driven by COVID-19 testing and stronger than expected routine testing.
Chief executive Dr Malcolm Parmenter told shareholders at the company’s annual meeting that despite the various lockdowns, revenue climbed to $689.9 million in the September quarter from $480.2 million a year ago.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
